A cross-sectional study of hyponatraemia among elderly patients with heart failure in Uganda

BMJ Open

Volumn 6, Issue 5, 2016, Pages

  Nankabirwa, Harriet ^a   Kalyesubula, Robert ^a   Ssinabulya, Isaac ^a   Katabira, Elly T ^a   Cumming, Robert G ^b  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LOOP DIURETIC AGENT; SODIUM; DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; AGING; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRAMINGHAM RISK SCORE; GROUPS BY AGE; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; PREVALENCE; SODIUM BLOOD LEVEL; TERTIARY CARE CENTER; UGANDA; VOMITING; BLOOD; COMORBIDITY; HEART FAILURE; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIURETICS; FEMALE; HEART FAILURE; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UGANDA; VOMITING;

EID: 84971216526     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009775     Document Type: Article

References (25)

1. MoH. Promoting peoples health to enhance socio-economic development. Health sector strategic & investiment plan. Kampala: MoH, 2010:30-1.
2. Bureau USC. International Programs. International programs-Information Gateway-USCensusgov. https://wwwcensusgov/population/international/data/idb/informationGatewayphp2016
3. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005;112:3577-83.
4. Luckey AE, Parsa CJ. Fluid and electrolytes in the aged. Arch Surg 2003;138:1055-60.
5. Tareen N, Martins D, Nagami G, et al. Sodium disorders in the elderly. J Natl Med Assoc 2005;97:217-24.
6. Miller M. Hyponatremia in the elderly: risk factors, clinical consequences, and management. Clin Geriatr 2009;17:34-9.
7. Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. Circulation 2005;111:2454-60.
8. Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 1994;128:564-74.
9. Balling L, Schou M, Videbaek L, et al. Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure. Eur J Heart Fail 2011;13:968-73.
10. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:A6-13.
11. Yamane T. Statistics; an introductory analysis. New York: Harper and Row, 1967.
12. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest J 1993;103:601-6.
13. Fusgen I. Disorders of water and sodium metabolism in older patients. Eur J Geriatr 2003. http://www.saltassociation.co.uk/wp/wp-content/uploads/IFusgen-Disordersofwaterandsodiummetabolisminolderpatients1.pdf
14. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-8.
15. Romanovsky A, Bagshaw S, Rosner MH. Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy. Int J Nephrol 2011;2011:732746.
16. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-56.
17. Association ESP. Salt and Elderly Forum. 2007. http://www.eusalt.com
18. Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff Resour Alloc 2006;4:10.
19. Adrogué HJ. Consequences of inadequate management of hyponatremia. Am J Nephrol 2005;25:240-9.
20. Cumming K, Hoyle GE, Hutchison JD, et al. Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures. PLoS ONE 2014;9:e88272.
21. Thompson CJ. Hyponatraemia: new associations and new treatments. Eur J Endocrinol 2010;162:S1-3.
22. Deitelzweig SB, McCormick L. Hyponatremia in hospitalized patients: the potential role of tolvaptan. Hospital Practice, 2011.
23. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342:1581-9.
24. Liamis G, Elisaf M. Hyponatremia induced by drugs. In:Simon EE, ed. Hyponatremia. New York: Springer, 2013:111-26.
25. Grimaldi A, Ammirati E, Karam N, et al. Cardiac surgery for patients with heart failure due to structural heart disease in Uganda: access to surgery and outcomes. Cardiovasc J Afr 2014;25:204.